Muscular Dystrophy Research Today is a free monthly online journal that collates and summarizes the latest research about Muscular Dystrophy, including details on duchenne muscular dystrophy, symptoms, treatment.

Volume 3 (2007), Issue 4 (April)

1. Decreased calcineurin activity in circulation of Duchenne muscular dystrophy.
   Clin Biochem, 40(7): 443-6. [Abstract] [Full-text]
2. MR spectroscopy and diffusion tensor imaging of the brain in congenital muscular dystrophy with merosin deficiency: metabolite level decreases, fractional anisotropy decreases, and apparent diffusion coefficient increases in the white matter.
   Brain Dev, 29(5): 317-21. [Abstract] [Full-text]
3. Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy.
   Pharmacoepidemiol Drug Saf, 16(4): 402-4. [Abstract] [Full-text]
4. Warming up improves speech production in patients with adult onset myotonic dystrophy.
   J Commun Disord, 40(3): 185-95. [Abstract] [Full-text]
5. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy.
   Genes Dev, 21(7): 770-83. [Abstract] [Full-text]
6. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
   J Clin Invest, 117(4): 889-901. [Abstract] [Full-text]
7. The role of free radicals in the pathophysiology of muscular dystrophy.
   J Appl Physiol, 102(4): 1677-86. [Abstract] [Full-text]
8. Lung inflation by glossopharyngeal breathing and "air stacking" in Duchenne muscular dystrophy.
   Am J Phys Med Rehabil, 86(4): 295-300. [Abstract] [Full-text]
9. MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy.
   Neuromuscul Disord, 17(4): 321-9. [Abstract] [Full-text]
10. A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex.
    Neuromuscul Disord, 17(4): 285-9. [Abstract] [Full-text]
11. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Neuromuscul Disord, 17(4): 306-12. [Abstract] [Full-text]
12. Desmin immunolocalisation in autosomal dominant Emery-Dreifuss muscular dystrophy.
    Neuromuscul Disord, 17(4): 297-305. [Abstract] [Full-text]
13. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis.
    Neuromuscul Disord, 17(4): 276-84. [Abstract] [Full-text]
14. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1.
    Am J Physiol Cell Physiol, 292(4): C1291-7. [Abstract] [Full-text]
15. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency.
    Gene Ther, 14(9): 733-40. [Abstract] [Full-text]
16. Predictive factors for the development of scoliosis in Duchenne muscular dystrophy.
    Eur J Paediatr Neurol, 11(3): 160-6. [Abstract] [Full-text]
17. Delayed developmental language milestones in children with Duchenne's muscular dystrophy.
    J Pediatr, 150(5): 474-8. [Abstract] [Full-text]
18. Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy.
    BMC Med Genet, 8: 19. [Abstract] [Full-text]

© 2005-2008 Muscular Dystrophy Research Today. All Rights Reserved.